Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy

Talaei, M. and Robertson, N. P. ORCID: 2022. Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy. Journal of Neurology 269 (1) , pp. 534-536. 10.1007/s00415-021-10908-9

[thumbnail of s00415-021-10908-9.pdf]
PDF - Published Version
Available under License Creative Commons Attribution.

Download (486kB) | Preview


Intravenous immunoglobulin (IVIg) plays a key role in treatment of inflammatory demyelinating polyneuropathies such as Guillain–Barre syndrome (GBS). However, individual response to treatment can be unpredictable, and for those most severely affected, a second dose of IVIg (SIV) is commonly administered despite limited evidence for efficacy. In this month’s journal club, we review two studies which explore the efficacy of second dosing and a third study exploring neurophysiological factors predicting relapse in chronic inflammatory polyneuropathy.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Publisher: Springer
ISSN: 0340-5354
Date of First Compliant Deposit: 16 March 2023
Date of Acceptance: 12 November 2021
Last Modified: 16 May 2023 14:40

Actions (repository staff only)

Edit Item Edit Item


Downloads per month over past year

View more statistics